DE1391524U - - Google Patents

Info

Publication number
DE1391524U
DE1391524U DENDAT1391524D DE1391524DU DE1391524U DE 1391524 U DE1391524 U DE 1391524U DE NDAT1391524 D DENDAT1391524 D DE NDAT1391524D DE 1391524D U DE1391524D U DE 1391524DU DE 1391524 U DE1391524 U DE 1391524U
Authority
DE
Germany
Prior art keywords
ßwax
youtileats
xejetung
xamt
wmmmt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1391524D
Other languages
German (de)
English (en)
Publication of DE1391524U publication Critical patent/DE1391524U/de
Active legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DENDAT1391524D Active DE1391524U (https=)

Publications (1)

Publication Number Publication Date
DE1391524U true DE1391524U (https=)

Family

ID=703164

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1391524D Active DE1391524U (https=)

Country Status (1)

Country Link
DE (1) DE1391524U (https=)

Similar Documents

Publication Publication Date Title
Kotani et al. Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant
DE1391524U (https=)
EP1678065A1 (de) Vorrichtung zum vereinzeln von flachen sendungen in stehender position aus einem sendungsstapel
EP2047857B1 (en) Agent for injection purposes comprising antibiotic, and solution for injection comprising the agent
Della Vedova et al. Aspergillosis in domestic and wild birds from Argentina
Ergin et al. Invasive aspergillosis in solid‐organ transplantation: report of eight cases and review of the literature
US10953078B2 (en) Treatment and/or prevention of sepsis
US20170128421A1 (en) Premix formulation for parenteral use and packaging thereof
DE69729425T2 (de) Nicht-virulentes Mycoplasma synoviae und Impfstoffe desselben
US20210285859A1 (en) Filter membranes as antifoam level safeguards
Mikami et al. Synergistic postantifungal effect of flucytosine and fluconazole on Candida albicans
Ostrosky-Zeichner et al. Effects of pentoxifylline or dexamethasone in combination with amphotericin B in experimental murine cerebral cryptococcosis: evidence of neuroexcitatory pathogenic mechanisms
US20040248770A1 (en) Process for ultrafiltration of an antifungal agent
DE1502554U (https=)
AU2016210773B2 (en) An anti-parasitic formulation and a method for treating parasitic infestations in an animal
US20220257578A1 (en) Composition and method for treating candida auris infection
EP2288267B1 (en) An enzymatic pre-mixture against gram negative bacteria colonization in the animal intestinal tract
Abdele PRODUCTION OF BENEFICIAL LOCAL MICROORGANISM SOLUTION FROM HARAMAYA UNIVERSITY COMPOUND AND EFFECT OF ITS APPLICATION RATE AND ENSILING PERIOD ON QUALITY OF BARLEY (HORDEUM VULGARE) STRAW SILAGE
Marín et al. PHARMACOKINETICS OF TILDIPIROSIN AFTER INTRAVENOUS ADMINISTRATION TO HORSES AND EVALUATION OF ITS POTENTIAL CARDIOTOXIC EFFECT
EP4431083A1 (en) Formulation of dalbavancin
Sumano et al. Bioequivalence comparison of seventeen commercial oral enrofloxacins against the original pioneer preparation in broilers
Flückiger et al. Pneumonia in the immuncompromised host
KIRAL et al. Candida utilis: A Rare Cause of Septicemia in Two Immunocompetent Patients in the Pediatric Intensive Care Unit Candida utilis: Çocuk Yoğun Bakım Ünitesinde İzlenen İki İmmünokompetan Hastada Nadir Bir Sepsis Etkeni
DE1451433U (https=)
Krumbhaar et al. THE RELATION OF THE SPLEEN TO BLOOD DESTRUCTION AND REGENERATION AND TO HEMOLYTIC JAUNDICE: VIII. Regeneration of the Blood of Splenectomized Dogs after the Administration of Hemolytic Agents.